The Ryan Foundation   Report issue

Foundation Phase 1
Founded: Fort Worth TX United States (1983)

Organization Overview

First Clinical Trial
2005
NCT00215527
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

Laronidase (Aldurazyme) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lysosomal Storage Diseases (Phase 1)

Mucopolysaccharidoses (Phase 1)

Mucopolysaccharidosis I (Phase 1)

Spinal Cord Compression (Phase 1)

Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 1